Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 308
Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S, Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d

Activities

Showing entries 6 - 10 out of 202

Wie lassen sich Elternschaft und Wissenschaft vereinbaren?

Veronika Wöhrer , Gerhard Ecker , Therese Garstenauer , Benjamin Herr , Alice Leal
Wie lassen sich Elternschaft und Wissenschaft an der Universität Wien vereinbaren?
Panel discussion, round table, Talk or oral contribution
13.6.2022 - 13.6.2022

Arzneistoffentwicklung in Zeiten personalisierter Medizin

Gerhard Ecker
APOKongress - Personalisierte Medizin und Pharmazie
Conference, Talk or oral contribution
19.6.2021 - 19.6.2021

In silico Toxicology - from prediction of transporter interaction profiles to toxicological read across and beyond

Gerhard Ecker
XII EWDD - 12th European Workshop in Drug Design
Conference, Talk or oral contribution
20.5.2019 - 20.5.2019

Research of new TTK kinase inhibitors by using structure-based pharmacophore modelling and docking experiments

Riccardo Martini , Katharina Schwartz , Gerhard Ecker
XII EWDD - 12th European Workshop in Drug Design
Conference, Poster presentation
19.5.2019 - 19.5.2019

The OMICS approach - the buzz that makes the world go round

Gerhard Ecker
24th EAHP Congress
Conference, Talk or oral contribution
27.3.2019 - 27.3.2019